Cardiac calcium handling on trial: targeting the failing cardiomyocyte signalosome

Circ Res. 2014 Jan 3;114(1):12-4. doi: 10.1161/CIRCRESAHA.113.302748.

Authors

Sven T Pleger¹, Philip Raake, Hugo A Katus, Patrick Most

Affiliation

¹ From the Molecular and Translational Cardiology, Department of Internal Medicine III (S.T.P., P.R., H.A.K., P.M.), DZHK (German Center for Cardiovascular Research), Partner site Heidelberg/Mannheim (H.A.K., P.M.), Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany; and Center for Translational Medicine, Department of Medicine, Thomas Jefferson University, Philadelphia, PA (P.M.).

PMID: 24385502
DOI: 10.1161/CIRCRESAHA.113.302748

No abstract available

Keywords: Editorials; calcium signaling; genetic therapy; heart failure.

Publication types

Editorial
Comment

MeSH terms

Female
Genetic Therapy*
Heart Failure / therapy*
Humans
Male
Sarcoplasmic Reticulum Calcium-Transporting ATPases / genetics*

Substances

Sarcoplasmic Reticulum Calcium-Transporting ATPases
ATP2A2 protein, human

Grants and funding

R01 HL092130/HL/NHLBI NIH HHS/United States